A Prospective Open-Label Trial of Long-Acting Liquid Methylphenidate for the Treatment of Attention Deficit/Hyperactivity Disorder in Intellectually Capable Adults with Autism Spectrum Disorder.

Conclusions: Our findings suggest that MPH-ER is effective and well-tolerated in the treatment of ADHD in HF-ASD adults. PMID: 31607204 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31607204?dopt=Abstract

Source: The World Journal of Biological Psychiatry - October 13, 2019 Category: Psychiatry Authors: Joshi G, DiSalvo M, Wozniak J, Ceranoglu TA, Yule A, Surman C, Fried R, Galdo M, Hoskova B, Belser A, Biederman J Tags: World J Biol Psychiatry Source Type: research